STOCK TITAN

Align Technology Inc - ALGN STOCK NEWS

Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.

Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.

The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.

Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.

In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.

Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.

The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.

Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.

Rhea-AI Summary

Align Technology has launched the Invisalign Outcome Simulator Pro, enhancing patient consultation through advanced visualization tools. Available on iTero Element Plus series scanners, it combines in-face simulations with 3D views of potential treatment outcomes, driving patient education and acceptance. This tool streamlines workflows and maximizes chair time for doctors, fostering efficiency. Dr. Johnathan Fitzpatrick emphasized its impact on treatment acceptance. The simulator will be featured at multiple upcoming conferences and is set for wider availability in the second half of 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none
-
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) has announced a $200 million accelerated stock repurchase program with Citibank, part of its $1 billion repurchase initiative. The ASR will start with an initial buyback of approximately 552,000 shares, concluding by July 26, 2022. CEO Joe Hogan will additionally purchase $2 million in stock, reflecting confidence in Align's growth potential and market opportunities. The company holds approximately $1.1 billion in cash, supporting this strategic initiative aimed at enhancing shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
buyback
-
Rhea-AI Summary

Align Technology reported Q1'22 total revenues of $973.2 million, up 8.8% year-over-year but down 5.6% sequentially. Q1'22 Clear Aligner revenues were $809.7 million, a 7.5% increase year-over-year but down 0.7% sequentially. The company faced challenges from COVID-19, inflation, and geopolitical issues, which affected volumes and margins. Despite these, Align remains optimistic about its market potential, targeting long-term revenue growth of 20-30%. The quarter had a diluted EPS of $1.70, with a non-GAAP EPS of $2.13.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.47%
Tags
Rhea-AI Summary

Align Technology, Inc. (Nasdaq: ALGN) will release its first-quarter 2022 financial results on April 27, 2022, at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the call via phone or through a live audio webcast on Align's Investor Relations website. An archived version will be available later. Align Technology specializes in clear aligners, intraoral scanners, and CAD/CAM software for digital dentistry, having treated over 12.2 million patients with its Invisalign system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
none
-
Rhea-AI Summary

Align Technology has announced the integration of Cone Beam Computed Tomography (CBCT) scan data into its ClinCheck treatment planning software. This feature enables orthodontists to visualize patients' roots, bones, and crowns in a 3D model, facilitating better treatment planning with Invisalign. This innovation allows for the management of complex cases and improves overall treatment outcomes. The feature is currently in technical design assessment and will be phased in across clients starting in late 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.09%
Tags
none
-
Rhea-AI Summary

Align Technology (ALGN) received notable recognition at the 2022 Institutional Investor’s Most Honored Companies Awards, with its CEO, CFO, and Investor Relations team ranked among the top in their categories. Joe Hogan placed third overall, while John Morici topped the Buy Side category. The Investor Relations program achieved second place in both Buy Side and Combined categories. Align's placement in the 'Most Honored Company' list reflects its effective communication and investor relations efforts during a challenging pandemic era.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.71%
Tags
none
Rhea-AI Summary

Align Technology, Inc. (Nasdaq: ALGN) has settled its patent infringement and antitrust litigation with 3Shape A/S, which commenced in November 2017. The litigation included various claims in federal courts and before the United States Patent Trial and Appeal Board. The settlement terms are confidential, but it is not expected to materially affect Align's operations or financial results. Invisalign customers will still be able to use 3Shape scanners for case submissions outside the U.S., China, and Japan. Align remains committed to innovation in digital orthodontics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.05%
Tags
none
-
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) announces significant innovations in its Invisalign system aimed at enhancing digital orthodontics. Key features include ClinCheck Live Update for real-time treatment plan modifications, the Invisalign Practice App for mobile management, and the Invisalign Personalized Plan (IPP) for streamlined treatment preferences. These enhancements are designed to improve efficiency, patient outcomes, and overall practice productivity. Align's commitment to continuous innovation is underscored by leveraging data from over 12 million cases, enhancing both the doctor and patient experience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none
-
Rhea-AI Summary

Align Technology reported Q4 2021 revenues of $1.03 billion, a 23.6% year-over-year increase. Full year revenue reached $4.0 billion, up 59.9%. Clear Aligner revenue was $3.2 billion, while Imaging Systems and CAD/CAM Services rose to $705.5 million, marking increases of 54.5% and 90.4% respectively. Q4 diluted EPS stood at $2.40; non-GAAP diluted EPS was $2.83. The company achieved significant milestones, serving over 12 million Invisalign patients. Looking ahead, Align anticipates 2022 revenue growth of 20%-30% despite potential Omicron impacts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) will report its fourth quarter and full year 2021 financial results on February 2, 2022, after market close. The results will be available on the company's Investor Relations website at 4:00 p.m. ET. Following this, a conference call will take place at 4:30 p.m. ET to discuss the results, accessible via an audio webcast. Tentative earnings release dates for fiscal 2022 are also announced, with the first quarter on April 27, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
none

FAQ

What is the current stock price of Align Technology (ALGN)?

The current stock price of Align Technology (ALGN) is $211.06 as of December 20, 2024.

What is the market cap of Align Technology (ALGN)?

The market cap of Align Technology (ALGN) is approximately 15.9B.

What is Align Technology's main product?

Align Technology’s main product is the Invisalign® System, the world’s most advanced clear aligner system.

How many patients have been treated with Invisalign?

Since its launch, Invisalign has treated over 17.6 million patients worldwide.

What technologies does Align Technology offer?

Align Technology offers Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software.

What is the iTero Lumina™ scanner?

The iTero Lumina™ is a next-generation intraoral scanner providing a wider field of capture, faster and more accurate scans, and superior patient comfort.

What was the purpose of acquiring Cubicure GmbH?

The acquisition of Cubicure GmbH aims to enhance Align’s 3D printing capabilities, supporting the development of innovative orthodontic solutions like the Invisalign Palatal Expander System.

How does Align Technology support scientific research?

Align Technology supports scientific research through its annual Research Awards Program, providing grants to universities for advancing dental care.

What is the Align Digital Platform?

The Align Digital Platform™ is an integrated suite of proprietary technologies and services designed to enhance digital orthodontic and restorative workflows.

How many Invisalign-trained doctors are there globally?

There are over 230,000 Invisalign-trained dentists and orthodontists worldwide.

What is the financial outlook for Align Technology?

Align Technology maintains robust financial health, with continuous investments in R&D and strategic acquisitions to drive future growth.

Where can I find more information about Align Technology’s products?

For more information, visit www.aligntech.com, www.invisalign.com, www.itero.com, or www.exocad.com.

Align Technology Inc

Nasdaq:ALGN

ALGN Rankings

ALGN Stock Data

15.94B
69.72M
6.6%
89.99%
4.01%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
TEMPE